The entire complement of Alsius products will continue to be offered by Zoll to meet the ongoing needs of Alsius customers and their patients. This includes both the Thermogard XP advanced temperature management system as well as the Cool Gard 3000 system.
Zoll intends to maintain the full line of Alsius catheters, all of which provide central venous infusion capabilities. To make this transition seamless for customers, Zoll will provide all warranty and service obligations relating to the installed base of Alsius products.
Zoll plans to consolidate the operations of the acquired business at its new 53,000 square foot facility in Sunnyvale, California, which has a separate production area designed specifically for catheter manufacturing.
Richard Packer, chairman and CEO of Zoll, said: “Temperature management is a critical component of our product portfolio. With this purchase, Zoll demonstrates its commitment to becoming a leader in accurate, easy-to-use and cost effective control of body temperature in critical care patients.”